Cassandra L. Chatwin

Statistics

Publications

Citations

313

H-Index

Active since

2018

Affiliations

VenatoRx Pharmaceuticals (United States)(Current)

University of North Texas System

University of North Texas Health Science Center

University of North Texas

Cassandra L. Chatwin is an author at VenatoRx Pharmaceuticals (United States) specializing in antibacterial pharmacotherapy, beta-lactam resistance, and beta-lactamase inhibitors.

Publications per year

2018–2021

Publications

VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in <i>Enterobacterales</i> and Pseudomonas aeruginosa

Jodie C. Hamrick, Jean‐Denis Docquier, Tsuyoshi Uehara et al. · Antimicrobial Agents and Chemotherapy · 2019 · 213 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes

Robert E. Lee Trout, Allison L. Zulli, Eugen F. Mesaros et al. · Journal of Medicinal Chemistry · 2021 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of <i>Enterobacterales</i> Expressing Extended-Spectrum β-Lactamases and Serine Carbapenemases

Cassandra L. Chatwin, Jodie C. Hamrick, Robert E. Lee Trout et al. · Antimicrobial Agents and Chemotherapy · 2021 · 35 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

1370. Cefepime/VNRX-5133 Broad-Spectrum Activity Is Maintained Against Emerging KPC- and PDC-Variants in Multidrug-Resistant K. pneumoniae and P. aeruginosa

Denis M. Daigle, Jodie C. Hamrick, Cassandra L. Chatwin et al. · Open Forum Infectious Diseases · 2018 · 18 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

1–4 of 4